Status | Study |
Not yet recruiting |
Study Name: MDM2 Inhibitor AMG-232, Carfilzomib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Condition: Hypercalcemia Plasmacytoma Re Date: 2017-01-25 Interventions: Drug: Carfilzomib Given IV |
Recruiting |
Study Name: Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel Condition: Hypercalcemia Date: 2016-09-05 Interventions: Genetic: genetic analysis with massively parallel sequencing |
Recruiting |
Study Name: Insulin Resistance in Primary Hyperparathyroidism Condition: Hyperparathyroidism Diabetes Hyperca Date: 2015-10-18 Interventions: Procedure: parathyroidectomy surgical treatment of hyperparathyroidism |
Completed |
Study Name: ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study Condition: Sarcoidosis Hypercalcemia Due to Sarcoidosis Date: 2014-05-30 Interventions: Drug: ACTHAR Gel (adrenocorticotropic hormone) ACTHAR GEL (adrenocorticotropic hormone) 80 units subcuta |
Active, not recruiting |
Study Name: Vitamin D and Preeclampsia Condition: Vitamin D Deficiency Defined as Serum 25OHD < 75 Nmol/l or 30ng/ml Preeclampsia Date: 2012-07-20 |
Completed |
Study Name: Differentially Expressed Proteins in Sporadic Parathyroid Tumors Condition: Primary Hyperparathyroidism Hypercalcemia Date: 2012-07-18 |
Completed |
Study Name: An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism Condition: Parathyroid Carcinoma Hypercalcemia Date: 2011-10-25 Interventions: Drug: Cinacalcet HCl Oral administration |
Withdrawn |
Study Name: The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to Exploration Condition: Hypercalcemia Hyperparathyroidism Date: 2010-10-21 |
Terminated |
Study Name: Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice Condition: Secondary Hyperparathyroidism End-Stage Renal Disease Date: 2010-05-28 Interventions: Drug: Paricalcitol Other Names |
Completed |
Study Name: Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects Condition: Hyperparathyroidism Hypercalcemia Date: 2010-01-04 Interventions: Other: Oral peptones load Enrolled subjects will receive 10 g Liebig meat extract diluted in 250ml of 0. |